Report Summary
Eternity Insights has published a new study on Global Liposome Drug Delivery Market focusing on key segments as by Type (Liposomal Doxorubicin,Liposomal Amphoteracin B,Liposomal Paclitaxel,Others), by Application (Cancer & Tumor Therapy,Fungal Infection Therapy,Others), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Liposome Drug Delivery Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Liposome Drug Delivery Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Liposome Drug Delivery Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Liposome Drug Delivery Market Segmentation:
Liposome Drug Delivery Market, By Type
- Liposomal Doxorubicin
- Liposomal Amphoteracin B
- Liposomal Paclitaxel
- Others
Liposome Drug Delivery Market, By Application
- Cancer & Tumor Therapy
- Fungal Infection Therapy
- Others
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Liposome Drug Delivery market in terms of demand generation. The Liposome Drug Delivery market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Liposome Drug Delivery market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Liposome Drug Delivery Market Taxonomy:
To learn more about this report
Global Liposome Drug Delivery Market Competitive Landscape
The global Liposome Drug Delivery market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Johnson & Johnson
- Gilead Sciences
- Pacira
- Sun Pharmaceutical
- Luye Pharma
- Sigma-Tau Group
- Fudan-Zhangjiang
- Teva Pharmaceutical
- CSPC
- Novartis
- Kingond Pharm
- Spectrum Pharmaceuticals
- Shanghai New Asia
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Liposomal Doxorubicin,Liposomal Amphoteracin B,Liposomal Paclitaxel,Others |
| By Application Outlook |
Cancer & Tumor Therapy,Fungal Infection Therapy,Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Johnson & Johnson,Gilead Sciences,Pacira,Sun Pharmaceutical,Luye Pharma,Sigma-Tau Group,Fudan-Zhangjiang,Teva Pharmaceutical,CSPC,Novartis,Kingond Pharm,Spectrum Pharmaceuticals,Shanghai New Asia |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
Global Liposome Drug Delivery Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 Liposome Drug Delivery Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Liposome Drug Delivery Industry Overview
2.1 Global Liposome Drug Delivery Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 Liposome Drug Delivery Global Import Market Analysis
2.1.2 Liposome Drug Delivery Global Export Market Analysis
2.1.3 Liposome Drug Delivery Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Liposomal Doxorubicin
2.2.2 Liposomal Amphoteracin B
2.2.3 Liposomal Paclitaxel
2.2.4 Others
2.3.2 Fungal Infection Therapy
2.3.3 Others
2.4.2 Global Liposome Drug Delivery Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Liposome Drug Delivery Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Liposome Drug Delivery Manufacturer Market Share
2.4.5 Top 10 Liposome Drug Delivery Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Liposome Drug Delivery Market
2.4.7 Key Manufacturers Liposome Drug Delivery Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Liposome Drug Delivery Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Liposome Drug Delivery Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Liposome Drug Delivery Market Size Categorized by Regions
4.1 Global Liposome Drug Delivery Revenue, Sales and Market Share by Regions
4.1.1 Global Liposome Drug Delivery Sales and Market Share by Regions (2015-2020)
4.1.2 Global Liposome Drug Delivery Revenue and Market Share by Regions (2015-2020)
4.2 Europe Liposome Drug Delivery Sales and Growth Rate (2015-2020)
4.3 APAC Liposome Drug Delivery Sales and Growth Rate (2015-2020)
4.4 North America Liposome Drug Delivery Sales and Growth Rate (2015-2020)
4.5 South America Liposome Drug Delivery Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Liposome Drug Delivery Sales and Growth Rate (2015-2020)
5 Europe Liposome Drug Delivery Market Size Categorized by Countries
5.1 Europe Liposome Drug Delivery Sales, Revenue and Market Share by Countries
5.1.1 Europe Liposome Drug Delivery Sales by Countries (2015-2020)
5.1.2 Europe Liposome Drug Delivery Revenue by Countries (2015-2020)
5.1.3 Germany Liposome Drug Delivery Sales and Growth Rate (2015-2020)
5.1.4 UK Liposome Drug Delivery Sales and Growth Rate (2015-2020)
5.1.5 France Liposome Drug Delivery Sales and Growth Rate (2015-2020)
5.1.6 Russia Liposome Drug Delivery Sales and Growth Rate (2015-2020)
5.1.7 Italy Liposome Drug Delivery Sales and Growth Rate (2015-2020)
5.1.8 Spain Liposome Drug Delivery Sales and Growth Rate (2015-2020)
5.2 Europe Liposome Drug Delivery Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Liposome Drug Delivery Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Liposome Drug Delivery Sales Market Share by Type (2015-2020)
5.3.2 Europe Liposome Drug Delivery Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Liposome Drug Delivery Sales Market Share by Application (2015-2020)
6 Asia-Pacific Liposome Drug Delivery Market Size Categorized by Countries
6.1 Asia-Pacific Liposome Drug Delivery Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Liposome Drug Delivery Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Liposome Drug Delivery Revenue by Countries (2015-2020)
6.1.3 China Liposome Drug Delivery Sales and Growth Rate (2015-2020)
6.1.4 Japan Liposome Drug Delivery Sales and Growth Rate (2015-2020)
6.1.5 Korea Liposome Drug Delivery Sales and Growth Rate (2015-2020)
6.1.6 India Liposome Drug Delivery Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Liposome Drug Delivery Sales and Growth Rate (2015-2020)
6.1.8 Australia Liposome Drug Delivery Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Liposome Drug Delivery Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Liposome Drug Delivery Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Liposome Drug Delivery Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Liposome Drug Delivery Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Liposome Drug Delivery Sales and Market Share by Application (2015-2020)
7 North America Liposome Drug Delivery Market Size Categorized by Countries
7.1 North America Liposome Drug Delivery Sales, Revenue and Market Share by Countries
7.1.1 North America Liposome Drug Delivery Sales by Countries (2015-2020)
7.1.2 North America Liposome Drug Delivery Revenue by Countries (2015-2020)
7.1.3 United States Liposome Drug Delivery Sales and Growth Rate (2015-2020)
7.1.4 Canada Liposome Drug Delivery Sales and Growth Rate (2015-2020)
7.1.5 Mexico Liposome Drug Delivery Sales and Growth Rate (2015-2020)
7.2 North America Liposome Drug Delivery Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Liposome Drug Delivery Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Liposome Drug Delivery Sales Market Share by Type (2015-2020)
7.3.2 North America Liposome Drug Delivery Revenue and Revenue Share by Type (2015-2020)
7.4 North America Liposome Drug Delivery Sales Market Share by Application (2015-2020)
8 South America Liposome Drug Delivery Market Size Categorized by Countries
8.1 South America Liposome Drug Delivery Sales, Revenue and Market Share by Countries
8.1.1 South America Liposome Drug Delivery Sales by Countries (2015-2020)
8.1.2 South America Liposome Drug Delivery Revenue by Countries (2015-2020)
8.1.3 Brazil Liposome Drug Delivery Sales and Growth Rate (2015-2020)
8.2 South America Liposome Drug Delivery Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Liposome Drug Delivery Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Liposome Drug Delivery Sales Market Share by Type (2015-2020)
8.3.2 South America Liposome Drug Delivery Revenue and Revenue Share by Type (2015-2020)
8.4 South America Liposome Drug Delivery Sales Market Share by Application (2015-2020)
9 Middle East and Africa Liposome Drug Delivery Market Size Categorized by Countries
9.1 Middle East and Africa Liposome Drug Delivery Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Liposome Drug Delivery Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Liposome Drug Delivery Revenue by Countries (2015-2020)
9.1.3 GCC Countries Liposome Drug Delivery Sales and Growth Rate (2015-2020)
9.1.4 Turkey Liposome Drug Delivery Sales and Growth Rate (2015-2020)
9.1.5 Egypt Liposome Drug Delivery Sales and Growth Rate (2015-2020)
9.1.6 South Africa Liposome Drug Delivery Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Liposome Drug Delivery Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Liposome Drug Delivery Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Liposome Drug Delivery Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Liposome Drug Delivery Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Liposome Drug Delivery Sales Market Share by Application (2015-2020)
10 Global Liposome Drug Delivery Market Segment by Type
10.1 Global Liposome Drug Delivery Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Liposome Drug Delivery Sales and Market Share by Type (2015-2020)
10.1.2 Global Liposome Drug Delivery Revenue and Market Share by Type (2015-2020)
10.2 Liposomal Doxorubicin Sales Growth Rate and Price
10.2.1 Global Liposomal Doxorubicin Sales Growth Rate (2015-2020)
10.2.2 Global Liposomal Doxorubicin Price (2015-2020)
10.3 Liposomal Amphoteracin B Sales Growth Rate and Price
10.3.1 Global Liposomal Amphoteracin B Sales Growth Rate (2015-2020)
10.3.2 Global Liposomal Amphoteracin B Price (2015-2020)
10.4 Liposomal Paclitaxel Sales Growth Rate and Price
10.4.1 Global Liposomal Paclitaxel Sales Growth Rate (2015-2020)
10.4.2 Global Liposomal Paclitaxel Price (2015-2020)
10.5 Others Sales Growth Rate and Price
10.5.1 Global Others Sales Growth Rate (2015-2020)
10.5.2 Global Others Price (2015-2020)
11.1 Global Liposome Drug DeliverySales Market Share by Application (2015-2020)
11.2 Cancer & Tumor Therapy Sales Growth Rate (2015-2020)
11.3 Fungal Infection Therapy Sales Growth Rate (2015-2020)
11.4 Others Sales Growth Rate (2015-2020)
12.1 Global Liposome Drug Delivery Revenue, Sales and Growth Rate (2020-2027)
12.2 Liposome Drug Delivery Market Forecast by Regions (2020-2027)
12.2.1 Europe Liposome Drug Delivery Market Forecast (2020-2027)
12.2.2 APAC Liposome Drug Delivery Market Forecast (2020-2027)
12.2.3 North America Liposome Drug Delivery Market Forecast (2020-2027)
12.2.4 South America Liposome Drug Delivery Market Forecast (2020-2027)
12.2.5 Middle East & Africa Liposome Drug Delivery Market Forecast (2020-2027)
12.3 Liposome Drug Delivery Market Forecast by Type (2020-2027)
12.3.1 Global Liposome Drug Delivery Sales Forecast by Type (2020-2027)
12.3.2 Global Liposome Drug Delivery Market Share Forecast by Type (2020-2027)
12.4 Liposome Drug Delivery Market Forecast by Application (2020-2027)
12.4.1 Global Liposome Drug Delivery Sales Forecast by Application (2020-2027)
12.4.2 Global Liposome Drug Delivery Market Share Forecast by Application (2020-2027)
13 Analysis of Liposome Drug Delivery Industry Key Manufacturers
13.1 Johnson & Johnson
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Johnson & Johnson Liposome Drug Delivery Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Johnson & Johnson News
13.2 Gilead Sciences
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Gilead Sciences Liposome Drug Delivery Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Gilead Sciences News
13.3 Pacira
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Pacira Liposome Drug Delivery Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Pacira News
13.4 Sun Pharmaceutical
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Sun Pharmaceutical Liposome Drug Delivery Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Sun Pharmaceutical News
13.5 Luye Pharma
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Luye Pharma Liposome Drug Delivery Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Luye Pharma News
13.6 Sigma-Tau Group
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Sigma-Tau Group Liposome Drug Delivery Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Sigma-Tau Group News
13.7 Fudan-Zhangjiang
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Fudan-Zhangjiang Liposome Drug Delivery Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Fudan-Zhangjiang News
13.8 Teva Pharmaceutical
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Teva Pharmaceutical Liposome Drug Delivery Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Teva Pharmaceutical News
13.9 CSPC
13.9.1 Company Details
13.9.2 Product Information
13.9.3 CSPC Liposome Drug Delivery Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 CSPC News
13.10 Novartis
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Novartis Liposome Drug Delivery Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 Novartis News
13.11 Kingond Pharm
13.11.1 Company Details
13.11.2 Product Information
13.11.3 Kingond Pharm Liposome Drug Delivery Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.11.4 Main Business Overview
13.11.5 Kingond Pharm News
13.12 Spectrum Pharmaceuticals
13.12.1 Company Details
13.12.2 Product Information
13.12.3 Spectrum Pharmaceuticals Liposome Drug Delivery Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.12.4 Main Business Overview
13.12.5 Spectrum Pharmaceuticals News
13.13 Shanghai New Asia
13.13.1 Company Details
13.13.2 Product Information
13.13.3 Shanghai New Asia Liposome Drug Delivery Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.13.4 Main Business Overview
13.13.5 Shanghai New Asia News
15 Appendix
